0000899243-20-018613.txt : 20200707
0000899243-20-018613.hdr.sgml : 20200707
20200707131255
ACCESSION NUMBER: 0000899243-20-018613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200702
FILED AS OF DATE: 20200707
DATE AS OF CHANGE: 20200707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mass Robert D.
CENTRAL INDEX KEY: 0001522224
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50484
FILM NUMBER: 201015789
MAIL ADDRESS:
STREET 1: C/O MARSHALL EDWARDS, INC.
STREET 2: 11975 EL CAMINO REAL, SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEI Pharma, Inc.
CENTRAL INDEX KEY: 0001262104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510407811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-369-7100
MAIL ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MARSHALL EDWARDS INC
DATE OF NAME CHANGE: 20030902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-02
0
0001262104
MEI Pharma, Inc.
MEIP
0001522224
Mass Robert D.
C/O MEI PHARMA, INC.
11455 EL CAMINO REAL, SUITE 250
SAN DIEGO
CA
92130
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
3.49
2020-07-02
4
A
0
230000
0.00
A
2030-07-02
Common Stock
230000
230000
D
Stock Option (Right to Buy)
1.57
2025-07-28
Common Stock
112500
112500
D
Stock Option (Right to Buy)
1.36
2026-07-29
Common Stock
135000
135000
D
Stock Option (Right to Buy)
2.83
2027-07-06
Common Stock
135000
135000
D
Stock Option (Right to Buy)
4.33
2028-06-22
Common Stock
100000
100000
D
Stock Option (Right to Buy)
4.28
2028-07-12
Common Stock
130000
130000
D
Stock Option (Right to Buy)
2.52
2029-07-01
Common Stock
230000
230000
D
One-quarter of such options shall vest on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
All of such options are presently exercisable.
One-quarter of such options vested on July 29, 2017 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 29, 2017.
One-quarter of such options vested on July 6, 2018 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 6, 2018.
One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
/s/ Brian G. Drazba, as attorney in fact
2020-07-02